HK1134136A1 - Methods for the diagnosis and risk assessment of plasmalogen deficiency mediated diseases of aging - Google Patents

Methods for the diagnosis and risk assessment of plasmalogen deficiency mediated diseases of aging

Info

Publication number
HK1134136A1
HK1134136A1 HK10101213.7A HK10101213A HK1134136A1 HK 1134136 A1 HK1134136 A1 HK 1134136A1 HK 10101213 A HK10101213 A HK 10101213A HK 1134136 A1 HK1134136 A1 HK 1134136A1
Authority
HK
Hong Kong
Prior art keywords
aging
diagnosis
methods
risk assessment
mediated diseases
Prior art date
Application number
HK10101213.7A
Other languages
English (en)
Inventor
Dayan Goodenowe
Original Assignee
Phenomenome Discoveries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phenomenome Discoveries Inc filed Critical Phenomenome Discoveries Inc
Publication of HK1134136A1 publication Critical patent/HK1134136A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00—Particle spectrometers or separator tubes
    • H01J49/0027—Methods for using particle spectrometers
    • H01J49/0031—Step by step routines describing the use of the apparatus
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00—Particle spectrometers or separator tubes
    • H01J49/26—Mass spectrometers or separator tubes
    • H01J49/34—Dynamic spectrometers
    • H01J49/36—Radio frequency spectrometers, e.g. Bennett-type spectrometers, Redhead-type spectrometers
    • H01J49/38—Omegatrons ; using ion cyclotron resonance
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7042—Aging, e.g. cellular aging

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Ecology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK10101213.7A 2007-04-13 2010-02-04 Methods for the diagnosis and risk assessment of plasmalogen deficiency mediated diseases of aging HK1134136A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91154807P 2007-04-13 2007-04-13
PCT/CA2008/000659 WO2008124916A1 (en) 2007-04-13 2008-04-09 Methods for the diagnosis and risk assessment of plasmalogen deficiency mediated diseases of aging

Publications (1)

Publication Number Publication Date
HK1134136A1 true HK1134136A1 (en) 2010-04-16

Family

ID=39863191

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10101213.7A HK1134136A1 (en) 2007-04-13 2010-02-04 Methods for the diagnosis and risk assessment of plasmalogen deficiency mediated diseases of aging

Country Status (8)

Country Link
US (2) US20100105101A1 (xx)
EP (1) EP2145181B1 (xx)
JP (1) JP5220842B2 (xx)
CN (1) CN101675337A (xx)
AU (1) AU2008238553B2 (xx)
CA (1) CA2680748C (xx)
HK (1) HK1134136A1 (xx)
WO (1) WO2008124916A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI475989B (zh) 2008-12-22 2015-03-11 Phenomenome Discoveries Inc 縮醛磷脂類化合物，含彼之醫藥組成物以及治療老化疾病的方法
CA2747582A1 (en) * 2009-01-02 2010-07-08 Nestec S.A. Methods for increasing endogenous plasmalogen levels
JP2012519199A (ja) 2009-03-04 2012-08-23 ネステク ソシエテ アノニム 哺乳動物における内因性プラスマローゲンレベルを上昇させる方法
CA2797960A1 (en) 2009-10-01 2011-04-07 Phenomenome Discoveries Inc. Serum-based biomarkers of pancreatic cancer and uses thereof for disease detection and diagnosis
WO2012090625A1 (ja) * 2010-12-28 2012-07-05 医療法人社団ブックス 認知症を血液サンプルで判定するための検査方法
US20140051105A1 (en) * 2011-01-17 2014-02-20 The Johns Hopkins University Mutant Proteins as Cancer-Specific Biomarkers
EP3612541A4 (en) * 2017-04-17 2020-12-23 Med-Life Discoveries LP CYCLIC PLASMENYLETHANOLAMINES
CN113244246B (zh) * 2021-05-11 2022-05-06 江南大学 一种微生物源缩醛磷脂在治疗结肠癌中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994009371A1 (en) * 1992-10-09 1994-04-28 Massachusetts Institute Of Technology Antemortem diagnostic test for alzheimer's disease
US5731354A (en) * 1996-05-06 1998-03-24 Clarion Pharmaceuticals Inc. Treatment for the inhibition of neuro-degenerative disease states
DE19836617C2 (de) * 1998-08-12 2001-02-08 Ulrich Frei In vitro Verfahren zur Erkennung und Diagnostik akuter koronarer Syndrome
US6177476B1 (en) * 1998-08-27 2001-01-23 Clarion Pharmaceuticals Inc. Nutritional supplements for replenishing plasmalogens
KR20010102069A (ko) * 1999-02-11 2001-11-15 추후제출 고효율 질량 분석
CA2298181C (en) * 2000-02-02 2006-09-19 Dayan Burke Goodnough Non-targeted complex sample analysis
CA2299210A1 (en) * 2000-02-17 2001-08-17 Gregory R. Wade A method of assessing the biological status of cancer development
WO2005085838A2 (en) 2004-03-02 2005-09-15 Vanderbilt University Computational analysis of mass spectroscopic lipid data
JP4176749B2 (ja) * 2005-07-29 2008-11-05 学校法人帝京大学 疾病検査法
US20080020472A1 (en) * 2005-11-22 2008-01-24 Frantz Biomarkers, Llc Method for detecting an inflammatory disease or cancer
US7491504B2 (en) * 2005-11-22 2009-02-17 Frantz Biomarkers, Llc Method for detecting ovarian cancer
CA2689848A1 (en) * 2006-02-28 2007-09-07 Phenomenome Discoveries Inc. Methods for the diagnosis of dementia and other neurological disorders

Also Published As

Publication number Publication date
JP5220842B2 (ja) 2013-06-26
WO2008124916A8 (en) 2009-01-15
JP2010523986A (ja) 2010-07-15
EP2145181B1 (en) 2012-12-26
EP2145181A1 (en) 2010-01-20
CA2680748C (en) 2012-08-28
WO2008124916A1 (en) 2008-10-23
US10302624B2 (en) 2019-05-28
CA2680748A1 (en) 2008-10-23
CN101675337A (zh) 2010-03-17
EP2145181A4 (en) 2011-01-12
AU2008238553B2 (en) 2014-06-19
US20160320366A1 (en) 2016-11-03
AU2008238553A1 (en) 2008-10-23
US20100105101A1 (en) 2010-04-29

Similar Documents

Publication Publication Date Title
HK1250393A1 (zh) 子癇前期檢測和治療的方法和組合物
HK1134136A1 (en) Methods for the diagnosis and risk assessment of plasmalogen deficiency mediated diseases of aging
IL207360A0 (en) Methods of diagnosing and treating parp - mediated diseases
HK1202558A1 (en) Compositions and methods for the therapy and diagnosis of influenza
GB2474146B (en) Methods of determining the health status of an individual
EP2265731A4 (en) METHODS AND COMPOSITION FOR EVALUATING MEDICATION RESPONSE
EP2444491B1 (en) Hyperglycosylated human coagulation factor IX
HK1158635A1 (en) Novel compounds useful for the treatment of degenerative and inflammatory diseases
HK1146894A1 (en) Compositions and methods for treating diseases of the nail
EP2361089A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED FUNCTION OF -SYNUCLEINE
EP2347256A4 (en) USE AND IDENTIFICATION OF BIOMARKERS FOR GASTROINTESTINAL DISEASES
PT2614832T (pt) Diagnóstico de pré-eclâmpsia
EP2288365A4 (en) TARGETED COOLING FACTORS AND METHOD OF APPLICATION THEREFOR
GB0808711D0 (en) Tissue assessment
EP2389104A4 (en) IDENTIFICATION OF THE LEVEL OF FETAL RISK DURING WORK
IL192319A0 (en) Assessment of medical conditions
EP2225559B8 (en) Assessment of physiological conditions
EP2173166A4 (en) POLYSIALIC ACID DE-N-ACETYLASE HEMMER AND METHOD OF USE THEREOF
EP2208986A4 (en) METHOD FOR DETERMINING SELF-INDUCER 2
HUP1100131A3 (en) Diagnosis of systemic diseases
EP2340436A4 (en) METHODS OF DIAGNOSING AND ASSESSING AUTOIMMUNE DISORDERS
EP2334813A4 (en) METHOD AND KITS FOR DIAGNOSIS OF RYR1-DEFICENT DISEASES
GB0808326D0 (en) Compositions and methods for the treatment of fybromyalgia
PL383160A1 (pl) Sposób i układ elektrod do pomiaru właściwości elektrycznych tkanek
PL383745A1 (pl) Metoda oceny stanu aparatu ruchu człowieka